Skip to main content
Login
Contact
Subscribe
Search form
Search
The Daily Times Leader
Click for weather forecast
Home
Forms
News
Sports
Classifieds
Obituaries
Entertainment
Local Guide
Special Sections
Talking About...
Photos
Videos
Games
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Achillion Pharmaceuticals
(NQ:
ACHN
)
6.760
USD
UNCHANGED
Last Price
Updated: 7:50 PM EST, Jan 27, 2020
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Achillion Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Achillion Pharmaceuticals Stock Forecast
March 04, 2020
Tags
Syndication Cloud
From
Syndication Cloud
Global Glioblastoma Multiforme Drugs Market Projected Could Reach $1.4 Billion By 2025
January 28, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Glioblastoma Multiforme Drugs Market Projected Could Reach $1.4 Billion By 2025
January 28, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
Achillion Shareholders Approve Agreement to be Acquired by Alexion
December 19, 2019
From
GlobeNewswire News Releases
Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who Have an Inadequate Response to Eculizumab Monotherapy at the 61st American
December 09, 2019
From
GlobeNewswire News Releases
Rigrodsky & Long, P.A. Files Class Action Suit Against Achillion Pharmaceuticals, Inc.
November 29, 2019
From
GlobeNewswire News Releases
Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corporation (ARTX) to Contact Firm
November 22, 2019
Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims involving the directors and officers regarding possible breaches of...
From
PR Newswire
European Medicines Agency Grants PRIME Designation to Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients Who Are Not Adequately Responding to a C5 Inhibitor
November 19, 2019
– Phase 3 PNH initiation planned early 2020 –
From
GlobeNewswire News Releases
Achillion Announces Clearance of Investigational New Drug Application for ACH-5228
November 11, 2019
From
GlobeNewswire News Releases
Merger Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies Is Fair to Shareholders - CISN, ACHN, VSI
November 07, 2019
From
ACCESSWIRE
Achillion Reports Third Quarter 2019 Financial Results and Provides Corporate Update
November 07, 2019
From
GlobeNewswire News Releases
SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders - AYR, WLH, ACHN
November 06, 2019
From
ACCESSWIRE
Achillion Announces Data Presentations at the 61st American Society of Hematology Annual Meeting
November 06, 2019
From
GlobeNewswire News Releases
Merger Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders – LPT, CISN, IPHS, ACHN
November 04, 2019
From
GlobeNewswire News Releases
Lifshitz & Miller LLP Announces Investigation of Achillion Pharmaceuticals, Inc., Anixter International Inc., Central European Media Enterprises Ltd., Digital Realty Trust, Inc., Fitbit, Inc., MutualF
November 04, 2019
From
PR Newswire
Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies Is Fair to Shareholders – RARX, ACHN, IPHS, CISN
November 01, 2019
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, ACHN, RARX Shareholders About Its Ongoing Investigations
October 29, 2019
From
GlobeNewswire News Releases
MERGER ALERT – ACHN, RARX, and IPHS: Levi & Korsinsky, LLP Notifies Investors of Investigations Concerning the Sale of these Companies
October 28, 2019
From
GlobeNewswire News Releases
Global Growth in Monoclonal Antibodies-How iCo Therapeutics Inc., Biogen, Provention Bio & Achillion Pharmaceuticals Win
October 28, 2019
Tags
h:worldnews
c:united/states
c:canada
From
EIN Presswire
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Acquisitions
October 24, 2019
From
GlobeNewswire News Releases
ACHILLION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Achillion Pharmaceuticals, Inc. - ACHN
October 24, 2019
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Achillion Pharmaceuticals, Inc. (NasdaqGS:...
From
Business Wire News Releases
SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues To Investigate Whether The Sale Of These Companies Is Fair To Shareholders - CISN, IPHS, ACHN
October 24, 2019
From
ACCESSWIRE
MERGER ALERT – ACHN, JAG, and ROAN: Levi & Korsinsky, LLP Notifies Investors of Investigations Concerning the Sale of these Companies
October 23, 2019
From
GlobeNewswire News Releases
Merger Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – IPHS, ACHN, RARX, TSG
October 22, 2019
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Investigates Achillion Pharmaceuticals, Inc.
October 18, 2019
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Achillion Pharmaceuticals, Inc. ("ACHN" or the "Company") (NASDAQ: ACHN) in connection with...
From
PR Newswire
SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues To Investigate Whether The Sale Of These Companies Is Fair To Shareholders - RARX, DOVA, ACHN
October 18, 2019
From
ACCESSWIRE
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) on Behalf of Achillion Shareholders and Encourages Achillion Investors to Contact
October 17, 2019
Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) on behalf of Achillion shareholders concerning the...
From
PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Achillion Pharmaceuticals, Inc. to Alexion Pharmaceuticals, Inc. is Fair to Shareholders
October 16, 2019
From
GlobeNewswire News Releases
ACHILLION MERGER INVESTIGATION: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Achillion Pharmaceuticals, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm
October 16, 2019
From
GlobeNewswire News Releases
Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Achillion Pharmaceuticals, Inc. has obtained a Fair Price in its sale to Alexion Pharmaceuticals, Inc.
October 16, 2019
Ademi & O'Reilly, LLP is investigating Achillion (NASDAQ:ACHN) for possible breaches of fiduciary duty and other violations of the law in connection with the sale of Achillion to Alexion.
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.